The aim of this study is to describe patient preferences on budesonide/formoterol fix dose combination for the treatment of their COPD, and to find those factors more strongly associated to a better attitude to medication.

Validation of questionnaire and assessment of patient satisfaction for budesonide/formoterol fix combination DPI in COPD

Inclusion Criteria:

• Provision of subject informed consent and to be an outpatient
• Clinical diagnosis of COPD according to ICD-10 classification, females and males, aged ≥ 40 years
• To be prescribed a fixed dose combination of inhaled budesonide/formoterol fix combination at least 3 months before the study start

Exclusion Criteria:

• Pregnancy for women
• Use of inhaled medication via a metered dose inhaler (pMDI)
• Currently participating in randomized clinical trials and being included in this study once

Patients of both sexes ≥ 40 years of age, diagnosed with COPD (according to ICD-10 criteria) and receiving budesonide/formoterol fix dose combination treatment by means of inhaler devices. The first prescription must be given at least 3 months prior to the study start and patient inclusion.